Skip to main content
. 2021 May 20;29(2):240–246. doi: 10.1007/s12529-021-10003-3

Fig. 1.

Fig. 1

Study flow diagram. Reasons for attrition include (n = 1) expected MORPH to include pharmaceutical intervention, (n = 1) death of a family member, and (n = 1) caregiving responsibilities. Note that control participants received the full MORPH program following completion of all testing procedures